Pulmonary gene delivery of hybrid vector, lipopolyplex containing N-lauroylsarcosine, via the systemic route

Journal of Controlled Release

Volumn 136, Issue 3, 2009, Pages 213-219

  Kurosaki, Tomoaki ^a   Kishikawa, Reiko ^a   Matsumoto, Megumi ^a   Kodama, Yukinobu ^a   Hamamoto, Tomoyuki ^a   To, Hideto ^a   Niidome, Takuro ^b   Takayama, Kozo ^c   Kitahara, Takashi ^a   Sasaki, Hitoshi ^a  

^a NAGASAKI UNIVERSITY HOSPITAL   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c HOSHI UNIVERSITY   (Japan)

Author keywords

Hybrid vector; Luciferase; N lauroylsarcosine; Polyethylenimine; Pulmonary gene delivery

Indexed keywords

HYBRID VECTOR; LUCIFERASE; N-LAUROYLSARCOSINE; POLYETHYLENIMINE; PULMONARY GENE DELIVERY;

BIOLOGICAL ORGANS; CHLORINE COMPOUNDS; NUCLEIC ACIDS; VECTORS; ZETA POTENTIAL;

GENE TRANSFER;

DRUG CARRIER; LIPOPOLYPLEX; N [1 (2,3 DIOLEYLOXY)PROPYL] N,N,N TRIMETHYLAMMONIUM CHLORIDE; N LAURYLSARCOSINE; PLASMID DNA; POLYETHYLENEIMINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL STRAIN HEPG2; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG FORMULATION; DRUG SAFETY; ERYTHROCYTE; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG; MALE; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PARTICLE SIZE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; TRANSGENE; ZETA POTENTIAL;

ANIMALS; CELL LINE, TUMOR; CELL SURVIVAL; ERYTHROCYTE AGGREGATION; HUMANS; LIPOSOMES; LUCIFERASES; LUNG; MALE; MICE; PARTICLE SIZE; PLASMIDS; POLYETHYLENEIMINE; QUATERNARY AMMONIUM COMPOUNDS; SARCOSINE; TRANSFECTION;

EID: 67349227205     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2009.02.005     Document Type: Article

References (32)

1. Griesenbach U., Ferrari S., Geddes D.M., and Alton E.W.F.W. Gene therapy progress and prospects: cystic fibrosis. Gene Ther. 9 (2002) 1344-1350
2. Stecenko A.A., and Brigham K.L. Gene therapy progress and prospects: alpha-1 antitrypsin. Gene Ther. 10 (2003) 95-99
3. Factor P. Gene therapy for asthma. Molec. Ther. 7 (2003) 148-152
4. Wang J.T., Peng D.Y., Chen M., and Ye J.S. Gene delivery for lung cancer using nonviral gene vectors. Pharmazie 62 (2007) 723-726
5. Keedy V., Wang W., Schiller J., Chada S., Slovis B., Coffee K., Worrell J., Thet L.A., Johnson D.H., and Carbone D.P. Phase I study of adenovirus p53 administered by bronchoalveolar lavage in patients with bronchioloalveolar cell lung carcinoma: ECOG 6597. J. Clin. Oncol. 1 26 (2008) 4166-4171
6. Kim T.W., Chung H., Kwon I.C., Sung H.C., Kang T.H., Han H.D., and Jeong S.Y. Induction of immunity against hepatitis B virus surface antigen by intranasal DNA vaccination using a cationic emulsion as a mucosal gene carrier. Mol. Cells 22 (2006) 175-181
7. Damjanovic D., Zhang X., Mu J., Medina M.F., and Xing Z. Organ distribution of transgene efficiency following intranasal mucosal delivery of recombinant replication-defective adenovirus gene transfer vector. Genet. Vaccines Ther. 6 (2008) 5
8. Shur J., Nevell T.G., Ewen R.J., Price R., Smith A., Barbu E., Conway J.H., Carroll M.P., Shute J.K., and Smith J.R. Cospray-dried unfractionated heparin with l-leucine as a dry powder inhaler mucolytic for cystic fibrosis therapy. J. Pharm. Sci. 97 (2008) 4857-4868
9. Weiss D.J. Delivery of DNA to lung airway epithelium. Methods Mol. Biol. 246 (2004) 53-68
10. Griesenbach U., Kitson C., Escudero Garcia S., Farley R., Singh C., Somerton L., Painter H., Smith R.L., Gill D.R., Hyde S.C., Chow Y.H., Hu J., Gray M., Edbrooke M., Ogilvie V., MacGregor G., Scheule R.K., Cheng S.H., Caplen N.J., and Alton E.W. Inefficient cationic lipid-mediated siRNA and antisense oligonucleotide transfer to airway epithelial cells in vivo. Respir. Res. 7 (2006) 26
11. Bragonzi A., Boletta A., Biffi A., Muggia A., Sersale G., Cheng S.H., Bordignon C., Assael B.M., and Conese M. Comparison between cationic polymers and lipids in mediating systemic gene delivery to the lungs. Gene Ther. 6 (1999) 1995-2004
12. Matsumoto M., Kishikawa R., Kurosaki T., Nakagawa H., Ichikawa N., Hamamoto T., To H., Kitahara T., and Sasaki H. Hybrid vector including polyethylenimine and cationic lipid, DOTMA, for gene delivery. Int. J. Pharm. 3 363 (2008) 58-65
13. Abraham J., and Bhat S.G. Permeabilization of baker's yeast with N-lauroyl sarcosine. J Ind Microbiol Biotechnol. 35 (2008) 799-804
14. Tetteh J., Howells S., Metcalfe E., and Suzuki T. Optimisation of radial basis function neural networks using biharmonic spline interpolation. Chemometr, Intell. Lab. Syst. 41 (1998) 17-29
15. Sandwell D.T. Biharmonic spline interpolation of GEOS-3 and SEASAT altimeter data. Geophys. Res. Lett. 14 (1987) 139-142
16. Wahba G. Spline Models for Observational Data (1990), Society for Industrial and Applied Mathematics, Philadelphia, PA
17. Takayama K., Fujikawa M., Obata Y., and Morishita M. Neural network based optimization of drug formulation. Adv. Drug Deliv. Rev. 55 (2003) 1217-1231
18. Edelstein M.L., Abedi M.R., and Wixon J. Gene therapy clinical trials worldwide to 2007-an update. J. Gene Med. 9 (2007) 833-842
19. Tang M.X., and Szoka F.C. The influence of polymer structure on the interactions of cationic polymers with DNA and morphology of the resulting complexes. Gene Ther. 4 (1997) 823-832
20. Fillion M.C., and Phillips N.C. Major limitations in the use of cationic liposomes for DNA delivery. Int. J. Pharm. 162 (1998) 159-170
21. Gao X., and Huang L. Cationic liposome-mediated gene transfer. Gene Ther. 2 (1995) 710-722
22. Goldman C.K., Soroceanu L., Smith N., Gillespie G.Y., Shaw W., Burgess S., Bilbao G., and Curiel D.T. In vitro and in vivo gene delivery mediated by a synthetic polycationic amino polymer. Nat. Biotechnol. 15 (1997) 462-466
23. Sorgi F.L., Bhattacharya S., and Huang L. Protamine sulfate enhances lipid-mediated gene transfer. Gene. Ther. 4 (1997) 961-968
24. Li S., and Huang L. In vivo gene transfer via intravenous administration of cationic lipid-protamine-DNA (LPD) complexes. Gene Ther. 4 (1997) 891-900
25. Lampela P., Elomaa M., Ruponen M., Urtti A., Männistö P.T., and Raasmaja A. Different synergistic roles of small polyethylenimine and Dosper in gene delivery. J. Control. Release 88 (2003) 173-183
26. Lee C.H., Ni Y.H., Chen C.C., Chou C., and Chang F.H. Synergistic effect of polyethylenimine and cationic liposomes in nucleic acid delivery to human cancer cells. Biochim. Biophys. Acta 1611 (2003) 55-62
27. García L., Buñuales M., Düzgüneş N., and Tros de Ilarduya C. Serum-resistant lipopolyplexes for gene delivery to liver tumour cells. Eur. J. Pharm. Biopharm. 67 (2007) 58-66
28. Dash P.R., Read M.L., Barrett L.B., Wolfert M.A., and Seymour L.W. Factors affecting blood clearance and in vivo distribution of polyelectrolyte complexes for gene delivery. Gene Ther. 6 (1999) 643-650
29. Tang G.P., Zeng J.M., Gao S.J., Ma Y.X., Shi L., Li Y., Too H.-P., and Wang S. Polyethylene glycol modified polyethylenimine for improved CNS gene transfer: effects of PEGylation extent. Biomaterials 24 (2003) 2351-2362
30. Bally M.B., Harvie P., Wong F.M.P., Kong S., Wasan E.K., and Reimer D.L. Biological barriers to cellular delivery of lipid-based DNA carriers. Adv. Drug Deliv. Rev. 38 (1999) 291-315
31. Ogris M., and Wagner E. Targeting tumors with non-viral gene delivery systems. Drug Discov. Today 15 7 (2002) 479-485
32. Wright M.J., Rosenthal E., Stewart L., Wightman L.M.L., Miller A.D., Latchman D.S., and Marber M.S. β-Galactosidase staining following intracoronary infusion of cationic liposomes in the in vivo rabbit heart is produced by microinfarction rather than effective gene transfer: a cautionary tale. Gene Ther. 5 (1998) 301-308